Profiling the human intestinal environment under physiological conditions.

Shalon D, Culver RN, Grembi JA, Folz J, Treit PV, Shi H, Rosenberger FA, Dethlefsen L, Meng X, Yaffe E, Aranda-Díaz A, Geyer PE, Mueller-Reif JB, Spencer S, Patterson AD, Triadafilopoulos G, Holmes SP, Mann M, Fiehn O, Relman DA, Huang KC. · 2023

Read Profiling the human intestinal environment under physiological conditions. by Shalon D, Culver RN, Grembi JA, Folz J, Treit PV, Shi H, Rosenberger FA, Dethlefsen L, Meng X, Yaffe E, Aranda-Díaz A, Geyer PE, Mueller-Reif JB, Spencer S, Patterson AD, Triadafilopoulos G, Holmes SP, Mann M, Fiehn O, Relman DA, Huang KC. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10191855.txt.

Introduction

Shalon and colleagues profile the human gut environment under normal, healthy conditions in a 2023 study. The gut's mix of microbes, proteins, and small chemicals changes along its length and over time. Those patterns shape digestion and health, yet most data came from stool alone, which gives only a partial view.

The team sampled directly from different gut regions in healthy volunteers. They mapped microbes and chemicals side by side at each site. The resulting atlas shows how much the gut's inner world varies by place, and sets a baseline for disease studies.

Catalog record

CREATORShalon D, Culver RN, Grembi JA, Folz J, Treit PV, Shi H, Rosenberger FA, Dethlefsen L, Meng X, Yaffe E, Aranda-Díaz A, Geyer PE, Mueller-Reif JB, Spencer S, Patterson AD, Triadafilopoulos G, Holmes SP, Mann M, Fiehn O, Relman DA, Huang KC.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE103 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10191855

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Profiling the human intestinal environment under physiological conditions By Dari Shalon, Rebecca Neal Culver, Jessica A. Grembi, Jacob Folz, Peter V. Treit, Handuo Shi, Florian A. Rosenberger, Les Dethlefsen, Xiandong Meng, Eitan Yaffe, Andrés Aranda-Díaz, Philipp E. Geyer Published in: Nature DOI: 10.1038/s41586-023-05989-7 ABSTRACT The spatiotemporal structure of the human microbiome1,2, proteome3 and metabolome4,5 reflects and determines regional intestinal physiology and may have implications for disease6. Yet, little is known about the distribution of microorganisms, their environment and their biochemical activity in the gut because of reliance on stool samples and limited access to only some regions of the gut using endoscopy in fasting or sedated individuals7. To address these deficiencies, we developed an ingestible device that collects samples from multiple regions of the human intestinal tract during normal digestion. Collection of 240 intestinal samples from 15 healthy individuals using the device and subsequent multi-omics analyses identified significant differences between bacteria, phages, host proteins and metabolites in the intestines versus stool. Certain microbial taxa were differentially enriched and prophage induction was more prevalent in the intestines than in stool. The host proteome and bile acid profiles varied along the intestines and were highly distinct from those of stool. Correlations between gradients in bile acid concentrations and microbial abundance predicted species that altered the bile acid pool through deconjugation. Furthermore, microbially conjugated bile acid concentrations exhibited amino acid-dependent trends that were not apparent in stool. Overall, non-invasive, longitudinal profiling of microorganisms, proteins and bile acids along the intestinal tract under physiological conditions can help elucidate the roles of the gut microbiome and metabolome in human physiology and disease. MAIN The human intestinal tract harbours the vast majority of microorganisms residing in or on our bodies1; their genetic content and biochemical transformation capabilities are hundreds of times larger than those encoded by the human genome8. Humans depend on their gut microorganisms for food digestion, immune system regulation and protection against pathogens, among other critical functions1. An important yet often overlooked aspect of the gut is regional heterogeneity and how it impacts local physiology9. Because of difficulties in accessing and sampling the intestinal tract, stool has been the main source of information for human gut microbiome studies10. However, stool reflects waste products and downstream effluent, within which regional variation is lost. For example, key metabolites such as bile acids are altered upstream by microbial transformations and then substantially absorbed by the host before excretion4. The regions of the gut distal to the stomach (duodenum, jejunum, ileum and colon) differ markedly in nutrient availability, pH, oxygen partial pressure, mucosal structure and flow rate7. As a result, distinct microbial communities with specialized functions, metabolomes, immune niches and proteomes are present in each intestinal region3,4,11. Thus, deeper understanding of how gut microorganisms impact human physiology and vice versa requires local sampling of the gut microbiome and its chemical environment in natural, unperturbed states. Historically, sampling the human intestinal tract without disturbance or contamination has been challenging10. We recently discovered substantial regional variability in microbiota composition across spatial scales of only a few inches throughout the intestines of deceased organ donors2. However, organ donors have typically been treated with antibiotics, and, even in cases in which the intestinal tract has been sampled immediately after cessation of life support, the gut is often ischaemic or necrotic. Duodenal sampling from live individuals using upper endoscopy has a high probability of inadvertent contamination from oral, oesophageal or gastric contents. Endoscopic access to the mid-jejunum requires a ~2-h procedure involving general anaesthesia or sedation, performed under fasting12,13. Alternatively, a stoma from exteriorization of the ileum through the abdominal wall can provide intestinal samples, but this procedure is invasive and reflects altered gut anatomy and physiology, at a single location14. Despite the important effects on the microbiome and signalling properties of bile acids, studies on their chemical diversity and concentrations have relied on non-representative measurements of the few percent of bile acids in stool or the fraction of a percent in blood. Previously developed ingestible devices for sampling the human intestinal tract have important limitations such as complex electronics15, large size that risks device retention15 or insufficient sampling volume for multi-omics analyses16. pH profiles, peristalsis, diet, physiology, gastrointestinal disorders and key metabolites such as bile acids17 differ markedly between humans and animals18, making human studies most relevant to human physiology and disease. To measure microbial, viral, proteomic and bile acid profiles within the human intestines during normal digestion, we developed and evaluated a capsule device that collects luminal contents from the small intestine or ascending colon. The expanding bladder and lack of internal structure in our device allowed ~400 µl of liquid to be retrieved, enabling multi-omic analyses. We report differences in microbiome composition, gene class abundance, prophage induction and the host proteome between the intestines and stool. We discovered gradients of microbially transformed bile acids along the intestinal tract and identified correlations between the abundance of microbially modified bile acids and specific gut bacterial species. In a separate manuscript, we combined five metabolomics assays to identify spatial and temporal differences between stool and intestinal metabolomes, including diet-derived compounds and microbially linked metabolites such as sulfonolipids and fatty acid esters of hydroxy fatty acid lipids19. These discoveries illuminate biological properties of the intestinal tract that are inaccessible from stool or endoscopic sampling. DEVICE FOR SAMPLING THE HUMAN INTESTINES The sampling capsule is a single-use, passive device that collects fluid from the human intestines for ex vivo analysis. The device contains a collapsed collection bladder capped by a one-way valve inside a dissolvable capsule with an enteric coating (Fig. 1a). The enteric coating prevents contact between the collection bladder and the surrounding environment before entry into the intestines. The pH of the intestines typically rises from 4–6 in the duodenum to 7–8 in the ileum15. Once the device reaches a pre-set pH sufficient to dissolve the enteric coating, the collection bladder expands and draws in luminal contents through the one-way valve. To sample from four distinct regions of the intestinal tract, four devices were ingested as a set after an individual ate a meal of their choosing, wherein different device types in a set were designed to open at different, progressively higher pH levels. Device type 4 included a time-delay coating to bias collection towards the ascending colon where the pH typically drops relative to the terminal ileum15 (Methods and Fig. 1a). Each device collects up to 400 µl of luminal contents; bacterial density is higher in the lumen than at or within the mucosa20, most mucosa-associated bacteria are represented in the luminal contents21 and many metabolites of interest are in the lumen. After the bladder fills, the one-way valve prevents further entrance of liquid. The ingested devices are recovered from stool, and collected samples are extracted for analysis. These devices provide unique potential for multi-region collection of microorganisms and metabolites within the intestines during normal digestion.Fig. 1Devices enable longitudinal sampling of the human intestine.a, Overview of the intended sampling locations (top) of the four device types in packaged form for ingestion (middle) and as full collection bladders containing intestinal samples after retrieval from stool (bottom). A US dime is included for scale. Top right, the device contains a folded bladder capped with

Read the complete text